Hospital
New York Community Hospital of Brooklyn INC
New York Community Hospital of Brooklyn INC was paid $7.79M by Medicaid between Aug 2018 and Dec 2024, across 92 billing codes. Its largest line is 99283, emergency room visit (moderate) — 29% of everything it billed.
33Billing provider infoNEW YORK COMMUNITY HOSPITAL OF BROOKLYN INC
BROOKLYN, NY 11229
BROOKLYN, NY 11229
33aNPI1215030697assigned 09/07/2006
33bProvider typeGeneral Acute Care Hospital
28Total paid$7.79M
24GClaims168,751
24DCodes billed92
24AFirst – last monthAug 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in New York
Rank by total paid#87 of 231
Median peer was paid$561K
This provider vs. median14×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 64 | $913.58 | |
| 2019 | 5,935 | $274K | |
| 2020 | 11,979 | $643K | |
| 2021 | 42,225 | $1.63M | |
| 2022 | 40,742 | $1.58M | |
| 2023 | 39,273 | $1.95M | |
| 2024incomplete | 28,533 | $1.71M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 29% | 14,104 | 13,167 | $2.26M |
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 19% | 9,319 | 8,944 | $1.44M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 8.7% | 4,303 | 4,207 | $677K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 7.4% | 3,579 | 3,421 | $577K |
| 70450 | Computed tomography, head or brain; without contrast material | 5.5% | 1,896 | 1,804 | $430K |
| 74160 | 5.3% | 1,370 | 1,359 | $416K | |
| 80053 | Comprehensive metabolic panel | 4.4% | 18,722 | 9,486 | $341K |
| J1439 | Injection, ferric carboxymaltose, 1 mg | 3.9% | 681 | 429 | $302K |
| 74150 | 3.2% | 991 | 980 | $246K | |
| 86769 | 3.1% | 19,168 | 8,431 | $238K | |
| 80048 | Basic metabolic panel (calcium, ionized) | 2.5% | 15,204 | 7,456 | $193K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | 1.2% | 606 | 552 | $96K |
80 more codes
| 71250 | <1% | 273 | $68K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 1,489 | $51K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 105 | $50K |
| 83880 | <1% | 1,308 | $40K | |
| 86905 | <1% | 972 | $36K | |
| 66984 | Extracapsular cataract removal with insertion of intraocular lens prosthesis | <1% | 15 | $31K |
| 87633 | Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets | <1% | 412 | $28K |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,755 | $25K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 14,015 | $23K |
| J1437 | Injection, ferric derisomaltose, 10 mg | <1% | 17 | $19K |
| 81025 | <1% | 6,148 | $19K | |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 24 | $16K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 530 | $15K |
| 87276 | <1% | 4,992 | $14K | |
| 82962 | <1% | 1,691 | $13K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 693 | $11K |
| 99232 | Hospital visit by a doctor, follow-up day | <1% | 254 | $11K |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 13 | $11K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 4,387 | $9K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 985 | $8K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,175 | $7K |
| 85732 | <1% | 4,045 | $7K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 263 | $6K |
| 99291 | Critical care, evaluation and management of the critically ill patient, first 30-74 minutes | <1% | 39 | $5K |
| 82803 | <1% | 149 | $5K | |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,019 | $4K |
| 96367 | <1% | 407 | $4K | |
| 88304 | <1% | 313 | $4K | |
| 81001 | <1% | 7,985 | $3K | |
| J2920 | Injection, methylprednisolone sodium succinate, up to 40 mg | <1% | 431 | $3K |
| 71045 | Radiologic examination, chest; single view | <1% | 1,829 | $3K |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | <1% | 185 | $3K |
| 99225 | <1% | 57 | $2K | |
| 96413 | Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance | <1% | 91 | $2K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 30 | $2K |
| 90715 | <1% | 45 | $1K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 126 | $1K |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 28 | $1K |
| 80076 | <1% | 86 | $1K | |
| M0239 | Intravenous infusion, bamlanivimab-xxxx, includes infusion and post administration monitoring | <1% | 36 | $1K |
| 84484 | <1% | 4,094 | $840.57 | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 14 | $673.06 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | <1% | 32 | $567.85 |
| 73620 | <1% | 456 | $565.77 | |
| 0012A | <1% | 13 | $458.54 | |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | <1% | 283 | $454.53 |
| 85379 | <1% | 1,413 | $395.10 | |
| 83690 | <1% | 3,270 | $352.81 | |
| M0247 | Intravenous infusion, sotrovimab, includes infusion and post administration monitoring | <1% | 49 | $305.60 |
| Q5106 | Injection, epoetin alfa-epbx, biosimilar, (retacrit) (for non-esrd use), 1000 units | <1% | 192 | $285.04 |
| 84702 | <1% | 1,193 | $228.10 | |
| 72170 | <1% | 53 | $220.91 | |
| 83605 | <1% | 1,009 | $182.46 | |
| 0011A | <1% | 12 | $157.25 | |
| 83735 | <1% | 1,201 | $119.14 | |
| 86140 | <1% | 993 | $114.19 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 184 | $106.89 |
| 73600 | <1% | 168 | $99.10 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 236 | $85.77 |
| 73560 | <1% | 218 | $75.92 | |
| 82550 | <1% | 545 | $75.87 | |
| 96368 | <1% | 16 | $55.55 | |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 1,014 | $51.95 |
| 82552 | <1% | 38 | $47.00 | |
| 73120 | <1% | 95 | $45.35 | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 186 | $36.32 |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 290 | $27.77 |
| 82150 | <1% | 130 | $25.90 | |
| 84480 | <1% | 225 | $17.59 | |
| 84436 | <1% | 223 | $17.59 | |
| 73030 | <1% | 12 | $15.00 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 74 | $5.99 |
| 85007 | <1% | 287 | $4.67 | |
| 82009 | <1% | 14 | $0.54 | |
| 84145 | 0% | 13 | $0.00 | |
| 90832 | Psychotherapy session, about 30 minutes | 0% | 12 | $0.00 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | 0% | 85 | $0.00 |
| J7644 | Ipratropium bromide, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose form, per milligram | 0% | 15 | $0.00 |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | 0% | 13 | $0.00 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | 0% | 21 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialDERDIK, JULIUS (CAO)